BioLineRx Stock

BioLineRx EBIT Margin

The EBIT Margin (Operating Margin) of BioLineRx (BLRX) as of Jul 15, 2026 is -158.58 %. In the previous year, EBIT Margin (Operating Margin) was -6.64 % — a change of 2,287.76% (lower).

EBIT Margin

-158.58 %

YoY

2,287.76%

Last updated:

EBIT Margin (Operating Margin) of BioLineRx is 2026 -158.58 % . EBIT Margin (Operating Margin) of BioLineRx was 2025 -6.64 % . It decreases by 2,287.76% lower compared to the previous year.

BioLineRx's operating (EBIT) margin stands at -158.6%, down from -18.7% several years earlier.

Access this data via the Eulerpool API

BioLineRx Stock analysis

What does BioLineRx do? BioLineRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioLineRx stock

EBIT Margin (Operating Margin) of BioLineRx is -158.58 % in 2026.

Access this data via the Eulerpool API

Margins — BioLineRx

All Key Metrics — BioLineRx